I wonder how many people read about the adverse events people are suffering. I think it would be very enlightening for them. Surprising how much similarity there is and disheartening to see how inept and disinterested the physician response is.
https://www.c19vaxreactions.com/real-stories.html
Cathi wrote: “I wonder how many people read about the adverse events people are suffering. I think it would be very enlightening for them.”
I wonder how many people read about the adverse events people who take HCQ and Ivermectin are suffering. I think it would be very enlightening for them.
Neither invermectin or HCQ have been approved for treating COVID.
Some of the side-effects that may be associated with ivermectin include skin rash, nausea, vomiting, diarrhea, stomach pain, facial or limb swelling, neurologic adverse events (dizziness, seizures, confusion), sudden drop in blood pressure, severe skin rash potentially requiring hospitalization and liver injury (hepatitis). Laboratory test abnormalities include decrease in white cell count and elevated liver tests. Any use of ivermectin for the prevention or treatment of COVID-19 should be avoided as its benefits and safety for these purposes have not been established. Data from clinical trials are necessary for us to determine whether ivermectin is safe and effective in treating or preventing COVID-19.
Hydroxychloroquine is associated with several rare but serious adverse reactions that may warrant immediate discontinuation of the medicine. Serious adverse reactions include ophthalmological, cardiomyopathy and QT prolongation, haematological, and neurological and neuromuscular reactions
15 Jun 2020. The U.S. Food and Drug Administration (FDA) revoked the emergency use authorization (EUA) that allowed for chloroquine phosphate and hydroxychloroquine sulfate donated to the Strategic National Stockpile to be used to treat certain hospitalized patients with COVID-19 when a clinical trial was unavailable, or participation in a clinical trial was not feasible. The agency determined that the legal criteria for issuing an EUA are no longer met. Based on its ongoing analysis of the EUA and emerging scientific data, the FDA determined that chloroquine and hydroxychloroquine are unlikely to be effective in treating COVID-19 for the authorized uses in the EUA. Additionally, in light of ongoing serious cardiac adverse events and other potential serious side effects, the known and potential benefits of chloroquine and hydroxychloroquine no longer outweigh the known and potential risks for the authorized use. This is the statutory standard for issuance of an EUA.
Those who believe in natural immunity should also read about the persistent ‘long haul’ complications in COVID survivors. I think that would be very enlightening for them.